Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Vallur, A C; Duthie, M S; Reinhart, C; Tutterrow, Y; Hamano, S; Bhaskar, K R H; Coler, R N; Mondal, D; Reed, S G

Vallur, A C; Duthie, M S; Reinhart, C; Tutterrow, Y; Hamano, S; Bhaskar, K R H; Coler, R N; Mondal, D; Reed, S G.

Affiliation

Vallur AC; Infectious Disease Research Institute, Seattle, WA, USA.

Clin Microbiol Infect ; 20(6): O374-83, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24237596

Subject(s)

Antibodies, Protozoan/blood; Biomarkers/analysis; DNA, Protozoan/isolation & purification; Leishmania/genetics; Leishmania/immunology; Leishmaniasis, Visceral/diagnosis; Adolescent; Adult; Bangladesh; Child; Child, Preschool; DNA, Protozoan/genetics; Female; Humans; Immunoassay/methods; Male; Real-Time Polymerase Chain Reaction

Key words

Asymptomatic infection; ELISA; PCR; biomarkers; intracellular pathogens; leishmania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Protozoan / Biomarkers / DNA, Protozoan / Leishmania / Leishmaniasis, Visceral Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google